DESMOID TUMORS MARKET ANALYSIS

Desmoid Tumors Market, By Drug Type (Non-steroidal anti-inflammatory drugs(NSAIDs), Targeted Therapy, Chemotherapy, Hormone Therapy, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Retail Pharmacies), and By Geography (Asia-Pacific , North America, Europe, South America, Middle East & Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Dec 2022
Code : CMI5449
Pages :457
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Desmoid Tumors Market: Restraint

The major factors that hinder growth of the global desmoid tumors market include high cost of desmoid tumors treatment drugs and side effects associated with chemotherapy and other desmoid tumor drugs. Many people who have had cancer treatment such as chemotherapy and radiation therapy have a risk of developing long-term side effects. These side effects can happen months or years after treatment, which is expected to act as a restraint for the market growth.For instance, chemotherapy and radiation therapy can cause some serious heart problems, lung problems, endocrine system problems, hormonal problems such as infertility, brain, spinal cord, and nerve problems, oral health and vision problems, digestion problems, among others.